Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |